{"id":46387,"date":"2026-01-29T18:11:45","date_gmt":"2026-01-29T21:11:45","guid":{"rendered":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/"},"modified":"2026-01-29T18:11:45","modified_gmt":"2026-01-29T21:11:45","slug":"a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie","status":"publish","type":"post","link":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/","title":{"rendered":"A Organon conclui a venda do Sistema JADA\u00ae para a Laborie"},"content":{"rendered":"<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Organon (NYSE: OGN), uma empresa global de sa\u00fade com a miss\u00e3o de fornecer medicamentos e solu\u00e7\u00f5es impactantes para um dia a dia mais saud\u00e1vel, anunciou hoje a conclus\u00e3o bem-sucedida da venda de seu Sistema JADA <b><sup>\u00ae<\/sup><\/b>para a Laborie Medical Technologies Corp. Consulte nosso comunicado anterior para obter um resumo dos <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.organon.com%2Fnews%2Forganon-announces-agreement-to-divest-its-jada-system-for-up-to-465-million-to-laborie%2F&amp;esheet=54406079&amp;newsitemid=20260127044407&amp;lan=pt-BR&amp;anchor=termos+da+transa%26ccedil%3B%26atilde%3Bo&amp;index=1&amp;md5=0513ea5d84b3dd38069d7e18bb4fbe95\" rel=\"follow\" shape=\"rect\" target=\"_blank\">termos da transa\u00e7\u00e3o<\/a>.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Indica\u00e7\u00f5es de Uso<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO Sistema JADA<sup>\u00ae<\/sup> destina-se ao controle e tratamento de sangramento ou hemorragia uterina anormal no p\u00f3s-parto, quando o tratamento conservador for indicado.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Contraindica\u00e7\u00f5es<\/b><\/p>\n<ul class=\"bwlistdisc\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n<li>\nGravidez intrauterina em curso<\/p>\n<\/li>\n<li>\nRuptura uterina n\u00e3o tratada<\/p>\n<\/li>\n<li>\nInvers\u00e3o uterina n\u00e3o resolvida<\/p>\n<\/li>\n<li>\nC\u00e2ncer cervical atual<\/p>\n<\/li>\n<li>\nAnomalia uterina conhecida<\/p>\n<\/li>\n<li>\nInfec\u00e7\u00e3o purulenta atual da vagina, colo do \u00fatero ou \u00fatero<\/p>\n<\/li>\n<li>\nPara cesarianas: Dilata\u00e7\u00e3o do colo do \u00fatero &lt;3 cm antes do uso do JADA<\/p>\n<\/li>\n<\/ul>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Advert\u00eancias<\/b><\/p>\n<ul class=\"bwlistdisc\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n<li>\nEvite for\u00e7a excessiva ao inserir o JADA no \u00fatero, pois pode ocorrer trauma na parede uterina, incluindo perfura\u00e7\u00e3o.<\/p>\n<\/li>\n<li>\nA seguran\u00e7a e a efic\u00e1cia do Sistema JADA em partos com idade gestacional &lt;34 semanas ou, em caso de gesta\u00e7\u00e3o m\u00faltipla, \u00fatero com tamanho &lt;34 semanas, n\u00e3o foram estabelecidas. Com \u00fateros menores, h\u00e1 potencial para aumento do risco de perfura\u00e7\u00e3o e expuls\u00e3o.<\/p>\n<\/li>\n<li>\nSinais de piora ou aus\u00eancia de melhora no quadro cl\u00ednico do paciente indicam a necessidade de reavalia\u00e7\u00e3o e, possivelmente, de tratamento e manejo mais agressivos da hemorragia p\u00f3s-parto (HPP)\/sangramento uterino anormal no p\u00f3s-parto.<\/p>\n<\/li>\n<li>\nO JADA n\u00e3o substitui o tratamento cir\u00fargico e a reposi\u00e7\u00e3o vol\u00eamica em casos de hemorragia p\u00f3s-parto com risco de vida\/sangramento uterino anormal no p\u00f3s-parto.<\/p>\n<\/li>\n<li>\nRemova o ar do Selo Cervical antes de usar o dispositivo para minimizar o risco de embolia gasosa caso o Selo Cervical se rompa.<\/p>\n<\/li>\n<li>\nPreencha sempre o Selo Cervical com fluido est\u00e9ril. Nunca o encha com ar, di\u00f3xido de carbono ou qualquer outro g\u00e1s para minimizar o risco de embolia gasosa caso o Selo Cervical se rompa.<\/p>\n<\/li>\n<\/ul>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Para relatar um evento adverso ou uma reclama\u00e7\u00e3o sobre a qualidade do produto JADA, ligue para 844-JADAMOM.<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Leia as <\/b><a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.organon.com%2Fproduct%2Fusa%2Fpi_circulars%2Fj%2Fjada%2Fjada_system_ifu_blue_seal.pdf&amp;esheet=54406079&amp;newsitemid=20260127044407&amp;lan=pt-BR&amp;anchor=Instru%26ccedil%3B%26otilde%3Bes+de+Uso&amp;index=2&amp;md5=9dd17321530da29a41a67e2e6c5116d0\" rel=\"follow\" shape=\"rect\" target=\"_blank\"><b>Instru\u00e7\u00f5es de Uso<\/b><\/a><b>para obter informa\u00e7\u00f5es importantes antes de usar o JADA.<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Sobre a Organon<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Organon (NYSE: OGN) \u00e9 uma empresa global de sa\u00fade com a miss\u00e3o de fornecer medicamentos e solu\u00e7\u00f5es impactantes para uma vida mais saud\u00e1vel todos os dias. Com um portf\u00f3lio de mais de 70 produtos nas \u00e1reas de Sa\u00fade da Mulher e Medicamentos Gerais, incluindo biossimilares, a Organon se concentra em atender \u00e0s necessidades de sa\u00fade que afetam as mulheres de forma \u00fanica, desproporcional ou diferenciada, ao mesmo tempo que amplia o acesso a tratamentos essenciais em mais de 140 mercados.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nCom sede em Jersey City, Nova Jersey, a Organon est\u00e1 comprometida em promover o acesso, a acessibilidade e a inova\u00e7\u00e3o na \u00e1rea da sa\u00fade. Saiba mais em <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttp%253A%252F%252Fwww.organon.com%252F%26data%3D05%257C02%257Ckarissa.peer%2540organon.com%257C2a379d4c8dbf455aa7aa08ddb7d84b0d%257C484a70d1caaf4a03a4771cbe688304af%257C0%257C0%257C638868861784863094%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DIs2jm5ATIX%252B7d2PdOK0JnWiDSOL6PKjlsiXC2a4AMgU%253D%26reserved%3D0&amp;esheet=54406079&amp;newsitemid=20260127044407&amp;lan=pt-BR&amp;anchor=www.organon.com&amp;index=3&amp;md5=b292ddef6df69298f04e8878b723fa01\" rel=\"follow\" shape=\"rect\" target=\"_blank\">www.organon.com<\/a> e nos siga no <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Forganon%252F%26data%3D05%257C02%257Ckarissa.peer%2540organon.com%257C2a379d4c8dbf455aa7aa08ddb7d84b0d%257C484a70d1caaf4a03a4771cbe688304af%257C0%257C0%257C638868861784886690%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DFIpnKa0lrxqYJiW8setMUJspluH6Pq%252Fxj6kvyPTOkxY%253D%26reserved%3D0&amp;esheet=54406079&amp;newsitemid=20260127044407&amp;lan=pt-BR&amp;anchor=LinkedIn&amp;index=4&amp;md5=f4ce6dd7773fc66590ce7db16aa3251d\" rel=\"follow\" shape=\"rect\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.instagram.com%252Forganonllc%252F%26data%3D05%257C02%257Ckarissa.peer%2540organon.com%257C2a379d4c8dbf455aa7aa08ddb7d84b0d%257C484a70d1caaf4a03a4771cbe688304af%257C0%257C0%257C638868861784896430%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DoU1PhzGjTSaUnvzR%252B3mYLUx0rFsuBH5ytDNcGBzXW%252Bs%253D%26reserved%3D0&amp;esheet=54406079&amp;newsitemid=20260127044407&amp;lan=pt-BR&amp;anchor=Instagram&amp;index=5&amp;md5=9219ff7ea13c4e2398f53e439202474e\" rel=\"follow\" shape=\"rect\" target=\"_blank\">Instagram<\/a>, <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fx.com%252FOrganonLLC%26data%3D05%257C02%257Ckarissa.peer%2540organon.com%257C2a379d4c8dbf455aa7aa08ddb7d84b0d%257C484a70d1caaf4a03a4771cbe688304af%257C0%257C0%257C638868861784906590%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3D6POfdhFhBzX9WGYmag6KsO8VzSF0rAeQ%252FSF0S1WS%252FOw%253D%26reserved%3D0&amp;esheet=54406079&amp;newsitemid=20260127044407&amp;lan=pt-BR&amp;anchor=X&amp;index=6&amp;md5=8578bf65c47dc989fd1ee311569793f5\" rel=\"follow\" shape=\"rect\" target=\"_blank\">X<\/a>, <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.youtube.com%252Fchannel%252FUCFXZcWljXuEhDkMCmZZ4Yzw%26data%3D05%257C02%257Ckarissa.peer%2540organon.com%257C2a379d4c8dbf455aa7aa08ddb7d84b0d%257C484a70d1caaf4a03a4771cbe688304af%257C0%257C0%257C638868861784916431%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3D%252FJs85K%252FN9WvoC8lZw2%252B3NdrnfvA67GAzt5a%252FdgrcWKk%253D%26reserved%3D0&amp;esheet=54406079&amp;newsitemid=20260127044407&amp;lan=pt-BR&amp;anchor=YouTube&amp;index=7&amp;md5=146554bdf83fbc961cee62625586236c\" rel=\"follow\" shape=\"rect\" target=\"_blank\">YouTube<\/a>, <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.tiktok.com%252F%2540organon_llc%26data%3D05%257C02%257Ckarissa.peer%2540organon.com%257C2a379d4c8dbf455aa7aa08ddb7d84b0d%257C484a70d1caaf4a03a4771cbe688304af%257C0%257C0%257C638868861784930587%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3D6zGPOlH8wxgUgH9peipHC1FfEk9x3D15QupsKmDCLkQ%253D%26reserved%3D0&amp;esheet=54406079&amp;newsitemid=20260127044407&amp;lan=pt-BR&amp;anchor=TikTok&amp;index=8&amp;md5=203c5e44ba9bcb8ac823d5244b514fb1\" rel=\"follow\" shape=\"rect\" target=\"_blank\">TikTok<\/a> e <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.facebook.com%252FOrganonLLC%252F%26data%3D05%257C02%257Ckarissa.peer%2540organon.com%257C2a379d4c8dbf455aa7aa08ddb7d84b0d%257C484a70d1caaf4a03a4771cbe688304af%257C0%257C0%257C638868861784944649%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DPpCGY6HQ5qetFNp7%252BeYBsbgTxeZeqnwGwLDK1rV6saE%253D%26reserved%3D0&amp;esheet=54406079&amp;newsitemid=20260127044407&amp;lan=pt-BR&amp;anchor=Facebook&amp;index=9&amp;md5=47c3909e17f174693026a1418b590997\" rel=\"follow\" shape=\"rect\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Nota de advert\u00eancia sobre declara\u00e7\u00f5es prospectivas<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nExceto por informa\u00e7\u00f5es hist\u00f3ricas, este comunicado de imprensa inclui &#8220;declara\u00e7\u00f5es prospectivas&#8221; de acordo com as disposi\u00e7\u00f5es de porto seguro da Lei de Reforma de Lit\u00edgios de Valores Mobili\u00e1rios Privados dos EUA de 1995, incluindo, entre outras, declara\u00e7\u00f5es sobre o pagamento de at\u00e9 US$ 25 milh\u00f5es, sujeito ao atingimento de determinadas metas de receita para 2026, e outras declara\u00e7\u00f5es sobre cren\u00e7as, objetivos, planos ou perspectivas futuras da Organon. Declara\u00e7\u00f5es prospectivas podem ser identificadas por palavras como \u201cmetas\u201d, \u201cpotencial\u201d, \u201cir\u00e1\u201d, \u201cespera\u201d, \u201cacredita\u201d, \u201cfuturo\u201d ou palavras de significado semelhante. Essas declara\u00e7\u00f5es s\u00e3o baseadas nas cren\u00e7as e expectativas atuais da administra\u00e7\u00e3o da Organon e est\u00e3o sujeitas a riscos e incertezas significativos. Se as premissas subjacentes se mostrarem imprecisas, ou se os riscos ou incertezas se materializarem, os resultados reais poder\u00e3o diferir materialmente daqueles estabelecidos nas declara\u00e7\u00f5es prospectivas. A Organon n\u00e3o assume nenhuma obriga\u00e7\u00e3o de atualizar publicamente qualquer declara\u00e7\u00e3o prospectiva, seja como resultado de novas informa\u00e7\u00f5es, eventos futuros ou outros. Fatores adicionais que podem fazer com que os resultados difiram materialmente daqueles descritos nas declara\u00e7\u00f5es prospectivas podem ser encontrados nos documentos da Organon arquivados na SEC, incluindo o Relat\u00f3rio Anual mais recente da Organon no Formul\u00e1rio 10-K, os Relat\u00f3rios Atuais no Formul\u00e1rio 8-K e os arquivamentos subsequentes na SEC, dispon\u00edveis no site da SEC (<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=54406079&amp;newsitemid=20260127044407&amp;lan=pt-BR&amp;anchor=www.sec.gov&amp;index=10&amp;md5=738542125eb129aca027ae84b9e09453\" rel=\"follow\" shape=\"rect\" target=\"_blank\">www.sec.gov<\/a>)<b>.<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO texto no idioma original deste an\u00fancio \u00e9 a vers\u00e3o oficial autorizada. As tradu\u00e7\u00f5es s\u00e3o fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que \u00e9 a \u00fanica vers\u00e3o do texto que tem efeito legal.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp\"><span class=\"bwct31415\"><\/span><\/p>\n<p id=\"mmgallerylink\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span id=\"mmgallerylink-phrase\">Ver a vers\u00e3o original em businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260127044407\/pt\/\" rel=\"follow\" target=\"_blank\">https:\/\/www.businesswire.com\/news\/home\/20260127044407\/pt\/<\/a><\/span><\/p>\n<p><b>Contato:<\/b><\/p>\n<p>\nContatos para a Imprensa:\n<\/p>\n<p>Janine Colavita\n<\/p>\n<p>(732) 861-3806<\/p>\n<p>\nFelicia Bisaro\n<\/p>\n<p>(646) 703-1807<\/p>\n<p>\nContatos para Investidores:\n<\/p>\n<p>Jennifer Halchak\n<\/p>\n<p>(201) 275-2711<\/p>\n<p><strong>Fonte: <\/strong><a href='http:\/\/www.businesswire.com\/portal\/site\/home\/' target='_blank'>BUSINESS WIRE<\/a><img src='https:\/\/api.dino.com.br\/v2\/news\/tr\/326744?partnerId=3197' alt=\"\" style=\"border:0px;width:1px;height:1px;\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Organon (NYSE: OGN), uma empresa global de sa\u00fade com a miss\u00e3o de fornecer medicamentos e solu\u00e7\u00f5es impactantes para um dia a dia mais saud\u00e1vel, anunciou hoje a conclus\u00e3o bem-sucedida da venda de seu Sistema JADA \u00aepara a Laborie Medical Technologies Corp. Consulte nosso comunicado anterior para obter um resumo dos termos da transa\u00e7\u00e3o. Indica\u00e7\u00f5es [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-46387","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A Organon conclui a venda do Sistema JADA\u00ae para a Laborie - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Organon conclui a venda do Sistema JADA\u00ae para a Laborie - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"og:description\" content=\"A Organon (NYSE: OGN), uma empresa global de sa\u00fade com a miss\u00e3o de fornecer medicamentos e solu\u00e7\u00f5es impactantes para um dia a dia mais saud\u00e1vel, anunciou hoje a conclus\u00e3o bem-sucedida da venda de seu Sistema JADA \u00aepara a Laborie Medical Technologies Corp. Consulte nosso comunicado anterior para obter um resumo dos termos da transa\u00e7\u00e3o. Indica\u00e7\u00f5es [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/\" \/>\n<meta property=\"og:site_name\" content=\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-29T21:11:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"headline\":\"A Organon conclui a venda do Sistema JADA\u00ae para a Laborie\",\"datePublished\":\"2026-01-29T21:11:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/\"},\"wordCount\":837,\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp\",\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/\",\"name\":\"A Organon conclui a venda do Sistema JADA\u00ae para a Laborie - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp\",\"datePublished\":\"2026-01-29T21:11:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A Organon conclui a venda do Sistema JADA\u00ae para a Laborie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\",\"name\":\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"description\":\"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/author\\\/dino\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Organon conclui a venda do Sistema JADA\u00ae para a Laborie - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/","og_locale":"pt_BR","og_type":"article","og_title":"A Organon conclui a venda do Sistema JADA\u00ae para a Laborie - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","og_description":"A Organon (NYSE: OGN), uma empresa global de sa\u00fade com a miss\u00e3o de fornecer medicamentos e solu\u00e7\u00f5es impactantes para um dia a dia mais saud\u00e1vel, anunciou hoje a conclus\u00e3o bem-sucedida da venda de seu Sistema JADA \u00aepara a Laborie Medical Technologies Corp. Consulte nosso comunicado anterior para obter um resumo dos termos da transa\u00e7\u00e3o. Indica\u00e7\u00f5es [&hellip;]","og_url":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/","og_site_name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","article_published_time":"2026-01-29T21:11:45+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp","type":"","width":"","height":""}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"DINO","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/#article","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/"},"author":{"name":"DINO","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"headline":"A Organon conclui a venda do Sistema JADA\u00ae para a Laborie","datePublished":"2026-01-29T21:11:45+00:00","mainEntityOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/"},"wordCount":837,"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp","articleSection":["Not\u00edcias Corporativas"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/","url":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/","name":"A Organon conclui a venda do Sistema JADA\u00ae para a Laborie - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/#primaryimage"},"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp","datePublished":"2026-01-29T21:11:45+00:00","author":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"breadcrumb":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260127044407r1&amp;sid=brdno&amp;distro=ftp"},{"@type":"BreadcrumbList","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/a-organon-conclui-a-venda-do-sistema-jada-para-a-laborie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ocanal.com\/noticias\/corporativas\/"},{"@type":"ListItem","position":2,"name":"A Organon conclui a venda do Sistema JADA\u00ae para a Laborie"}]},{"@type":"WebSite","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website","url":"https:\/\/ocanal.com\/noticias\/corporativas\/","name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","description":"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ocanal.com\/noticias\/corporativas\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff","name":"DINO","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","caption":"DINO"},"url":"https:\/\/ocanal.com\/noticias\/corporativas\/author\/dino\/"}]}},"_links":{"self":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/46387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/comments?post=46387"}],"version-history":[{"count":0,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/46387\/revisions"}],"wp:attachment":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/media?parent=46387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/categories?post=46387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/tags?post=46387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}